Literature DB >> 21316200

Electrocardiographic signs of autonomic imbalance in medicated patients with first-episode schizophrenia spectrum disorders--relations to first treatment discontinuation and five-year remission status.

Robert Bodén1, Leif Lindström, Pentti Rautaharju, Johan Sundström.   

Abstract

PURPOSE: To explore measures in electrocardiograms (ECG) influenced by autonomic balance in early schizophrenia spectrum disorders and to examine their relation to subsequent first antipsychotic pharmacotherapy discontinuation and five-year remission status. SUBJECTS AND METHODS: Twelve-lead ECGs were recorded at baseline in 58 patients with first-episode schizophrenia spectrum disorders and in 47 healthy controls of similar age. Selected ECG variables included heart rate and measures of repolarization. Pharmacotherapy data were extracted from medical records. At a five-year follow-up the patients were interviewed and assessed with the positive and negative syndrome scale.
RESULTS: Patients had higher heart rate and a different ST-T pattern than the controls. High T-wave amplitudes in the leads aVF and V5 and ST-elevations in V5 were associated both with higher risk of an earlier discontinuation of first antipsychotic pharmacotherapy and with non-remission five years later. DISCUSSION AND
CONCLUSION: In this longitudinal cohort study, simple ECG measures influenced by autonomic balance in the early phase of schizophrenia spectrum disorders contained prognostic information. As this is the first report of this association and is based on a relatively small sample, the results should be interpreted with caution.
Copyright © 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21316200     DOI: 10.1016/j.eurpsy.2010.12.002

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  1 in total

1.  QT dynamics during treatment with sertindole.

Authors:  Jimmi Nielsen; Fan Wang; Claus Graff; Jørgen K Kanters
Journal:  Ther Adv Psychopharmacol       Date:  2015-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.